4.7 Article

Multilevel Approach for the Treatment of Giardiasis by Targeting Arginine Deiminase

Related references

Note: Only part of the references are listed.
Review Biochemistry & Molecular Biology

Recent Advances in the Development of Broad-Spectrum Antiprotozoal Agents

Antonio Moreno-Herrera et al.

Summary: Parasitic infections caused by various protozoa affect millions of people worldwide annually, with limited pharmacological treatments. Developing new and more effective drugs could be crucial in improving therapy outcomes for parasitic diseases.

CURRENT MEDICINAL CHEMISTRY (2021)

Article Chemistry, Medicinal

Anti-Giardia Drug Discovery: Current Status and Gut Feelings

Andrew Riches et al.

JOURNAL OF MEDICINAL CHEMISTRY (2020)

Review Nutrition & Dietetics

Role of the Synthetic B1 Vitamin Sulbutiamine on Health

Bernardo Starling-Soares et al.

JOURNAL OF NUTRITION AND METABOLISM (2020)

Article Multidisciplinary Sciences

On the molecular and cellular effects of omeprazole to further support its effectiveness as an antigiardial drug

Gabriel Lopez-Velazquez et al.

SCIENTIFIC REPORTS (2019)

Review Biochemistry & Molecular Biology

Epigenetics in the early divergent eukaryotic Giardia duodenalis: An update

Francisco Alejandro Lagunas-Rangel et al.

BIOCHIMIE (2019)

Article Parasitology

Giardia lamblia: identification of molecules that contribute to direct mast cell activation

Samira Munoz-Cruz et al.

PARASITOLOGY RESEARCH (2018)

Review Infectious Diseases

Treatment-refractory giardiasis: challenges and solutions

Marco Lalle et al.

INFECTION AND DRUG RESISTANCE (2018)

Article Biochemistry & Molecular Biology

Insights into the structure and inhibition of Giardia intestinalis arginine deiminase: homology modeling, docking, and molecular dynamics studies

Pedro Josue Trejo-Soto et al.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2016)

Article Parasitology

Evaluation of Giardia lamblia thioredoxin reductase as drug activating enzyme and as drug target

David Leitsch et al.

INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2016)

Article Microbiology

Giardial Triosephosphate Isomerase as Possible Target of the Cytotoxic Effect of Omeprazole in Giardia lamblia

Horacio Reyes-Vivas et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)

Article Chemistry, Medicinal

Antiprotozoal activity of proton-pump inhibitors

Jaime Perez-Villanueva et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)

Article Pharmacology & Pharmacy

THE VALUE OF DRUG REPOSITIONING IN THE CURRENT PHARMACEUTICAL MARKET

Edward L. Tobinick

DRUG NEWS & PERSPECTIVES (2009)

Article Biochemistry & Molecular Biology

Unraveling the mechanisms of tryptophan fluorescence quenching in the triosephosphate isomerase from Giardia lamblia

Gloria Hernandez-Alcantara et al.

BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2008)

Article Cell Biology

Arginine deiminase has multiple regulatory roles in the biology of Giardia lamblia

Maria Carolina Touz et al.

JOURNAL OF CELL SCIENCE (2008)

Article Multidisciplinary Sciences

Genomic minimalism in the early diverging intestinal parasite Giardia lamblia

Hilary G. Morrison et al.

SCIENCE (2007)

Article Biochemistry & Molecular Biology

Disulfide bridges in the mesophilic triosephosphate isomerase from Giardia lamblia are related to oligomerization and activity

Horacio Reyes-Vivas et al.

JOURNAL OF MOLECULAR BIOLOGY (2007)

Review Pharmacology & Pharmacy

Predicting protein druggability

PJ Hajduk et al.

DRUG DISCOVERY TODAY (2005)

Article Biochemistry & Molecular Biology

An unusual triosephosphate isomerase from the early divergent eukaryote Giardia lamblia

G López-Velázquez et al.

PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2004)

Review Microbiology

Biology of Giardia lamblia

RD Adam

CLINICAL MICROBIOLOGY REVIEWS (2001)

Article Biochemistry & Molecular Biology

The Protein Data Bank

HM Berman et al.

NUCLEIC ACIDS RESEARCH (2000)